The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 04, 2019
Filed:
May. 16, 2016
Applicant:
Pfizer Inc., New York, NY (US);
Inventors:
Agustin Casimiro-Garcia, Concord, MA (US);
Jeffrey Scott Condon, Melrose, MA (US);
Andrew Christopher Flick, East Lyme, CT (US);
Ariamala Gopalsamy, Lexington, MA (US);
Steven J. Kirincich, Concord, MA (US);
John Paul Mathias, Concord, MA (US);
Joseph Walter Strobach, Wentzville, MO (US);
Jason Shaoyun Xiang, Winchester, MA (US);
Li Huang Xing, Lexington, MA (US);
Xiaolun Wang, San Diego, CA (US);
Assignee:
Pfizer Inc., New York, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 239/42 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); A61K 31/505 (2006.01); C07D 239/28 (2006.01); C07D 241/14 (2006.01); A61P 1/00 (2006.01); A61P 1/04 (2006.01); A61P 35/00 (2006.01); C07D 405/10 (2006.01);
U.S. Cl.
CPC ...
C07D 239/42 (2013.01); A61K 31/505 (2013.01); A61P 1/00 (2018.01); A61P 1/04 (2018.01); A61P 35/00 (2018.01); C07D 239/28 (2013.01); C07D 241/14 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07D 405/10 (2013.01);
Abstract
Compounds, pharmaceutically acceptable salts thereof, are disclosed wherein the compounds have the structure of as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.